Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease

Table 1 Anthropometric characteristics and laboratory values of participants (mean ± SD)

Characteristics	Men (n = 2860)	Women (n = 2192)	P value
Age (yr)	44.77 ± 16.77	43.78 ± 15.43	0.0216
Weight (kg)	76.70 ± 15.05	72.60 ± 14.36	< 0.0001
Height (cm)	169.94 ± 8.02	156.40 ± 7.05	< 0.0001
WC (cm)	90.76 ± 12.32	91.55 ± 13.89	0.0199
DBP (mmHg)	76.61 ± 12.69	75.82 ± 13.05	0.0191
SBP (mmHg)	117.42 ± 15.76	115.42 ± 17.60	< 0.0001
MAP (mmHg)	90.22 ± 12.90	89.01 ± 13.62
BMI (kg/m2)			< 0.0001
mean ± SD	26.46 ± 4.60	29.65 ± 5.67
Prevalence of BMI ≥ 30 (%)	21.6 (20.2-23.0)	47.3 (45.4-49.3)
TG (mg/dL)	145.55 ± 98.25	141.12 ± 95.99	0.0966
HDL (mg/dL)	43.37 ± 11.48	46.42 ± 12.08	< 0.0001
Cholesterol	178.49 ± 41.95	189.47 ± 43.20	< 0.0001
ALT (U/L)	26.46 ± 19.04	19.59 ± 14.03	< 0.0001
AST (U/L)	23.98 ± 12.65	19.98 ± 9.71	< 0.0001
GGT (U/L)	29.90 ± 28.61	25.62 ± 21.64	< 0.0001
FBS	98.62 ± 29.86	103.98 ± 41.30	< 0.0001
Insulin (mU/L)	8.87 ± 6.74	10.36 ± 6.88	< 0.0001
HOMA-IR	2.19 ± 1.90	2.72 ± 2.45	< 0.0001
FLI	45.76 ± 28.93	52.24 ± 29.87	< 0.0001

ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BMI: Body Mass Index; DBP: Diastolic blood pressure; GGT: Gamma glutamyl transferase; FBS: Fasting blood sugar; FLI: Fatty liver index; HDL: High-density lipoprotein; HOMA-IR: Homeostasis Model Assessments-insulin resistance; LDL: Low-density lipoprotein; MAP: Mean arterial pressure; SBP: Systolic blood pressure; SD: Standard deviation; TG: Triglyceride; WC: Waist circumference.